tradingkey.logo


tradingkey.logo


ICU Medical Inc

ICUI
124.190USD
-3.460-2.71%
āļ›āļīāļ” 03/27, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
1.75BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
4180.07P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ ICU Medical Inc āļšāļĢāļīāļĐāļąāļ—

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.

āļ‚āđ‰āļ­āļĄāļđāļĨ ICU Medical Inc


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™ICUI
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—ICU Medical Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMar 31, 1992
āļ‹āļĩāļ­āļĩāđ‚āļ­Jain (Vivek)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™15000
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Mar 31
āļ—āļĩāđˆāļ­āļĒāļđāđˆ951 Calle Amanecer
āđ€āļĄāļ·āļ­āļ‡SAN CLEMENTE
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX - NASDAQ BASIC
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ92673-6212
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ19493662183
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.icumed.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™ICUI
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMar 31, 1992
āļ‹āļĩāļ­āļĩāđ‚āļ­Jain (Vivek)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ ICU Medical Inc


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
215.53K
+27.99%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
71.75K
+57.70%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
46.31K
+86.85%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
24.60K
+54.08%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
8.46K
+14.18%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
4.75K
+36.27%
Ms. Laurie Hernandez
Ms. Laurie Hernandez
Independent Director
Independent Director
3.61K
+47.75%
Ms. Kolleen T. Kennedy
Ms. Kolleen T. Kennedy
Independent Director
Independent Director
3.29K
+52.45%
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
3.25K
--
Mr. John Mills
Mr. John Mills
Investor Relations
Investor Relations
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
215.53K
+27.99%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
71.75K
+57.70%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
46.31K
+86.85%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
24.60K
+54.08%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
8.46K
+14.18%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
4.75K
+36.27%

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Infusion Consumables
285.09M
53.09%
Consumables
285.09M
53.09%
Infusion Systems
173.91M
32.39%
Vital Care
77.99M
14.52%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
United States
307.13M
57.19%
EMEA
115.09M
21.43%
APAC
57.48M
10.70%
Others
57.29M
10.67%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Infusion Consumables
285.09M
53.09%
Consumables
285.09M
53.09%
Infusion Systems
173.91M
32.39%
Vital Care
77.99M
14.52%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 21 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 21 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
13.29%
The Vanguard Group, Inc.
10.97%
Janus Henderson Investors
10.44%
Wasatch Global Investors Inc
10.00%
Fuller & Thaler Asset Management Inc.
5.13%
āļ­āļ·āđˆāļ™ āđ†
50.17%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
13.29%
The Vanguard Group, Inc.
10.97%
Janus Henderson Investors
10.44%
Wasatch Global Investors Inc
10.00%
Fuller & Thaler Asset Management Inc.
5.13%
āļ­āļ·āđˆāļ™ āđ†
50.17%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor/Hedge Fund
56.66%
Investment Advisor
45.50%
Hedge Fund
7.20%
Research Firm
3.13%
Corporation
1.90%
Individual Investor
1.67%
Sovereign Wealth Fund
1.65%
Pension Fund
1.33%
Bank and Trust
0.68%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
614
29.41M
119.11%
+2.29M
2025Q3
610
27.90M
113.00%
+1.26M
2025Q2
610
25.98M
105.53%
-2.00M
2025Q1
626
27.13M
110.25%
-2.28M
2024Q4
608
26.46M
107.92%
-3.56M
2024Q3
587
26.75M
109.35%
-2.77M
2024Q2
567
27.24M
111.60%
-1.50M
2024Q1
579
26.01M
106.82%
-1.69M
2023Q4
588
25.74M
106.69%
-1.14M
2023Q3
580
26.53M
109.94%
-1.49M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
BlackRock Institutional Trust Company, N.A.
3.22M
13.04%
-42.28K
-1.30%
Sep 30, 2025
The Vanguard Group, Inc.
2.62M
10.61%
-33.51K
-1.26%
Sep 30, 2025
Janus Henderson Investors
2.47M
10.02%
+3.39K
+0.14%
Sep 30, 2025
Wasatch Global Investors Inc
2.47M
10.01%
+2.47M
--
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.39M
5.61%
-4.81K
-0.35%
Sep 30, 2025
State Street Investment Management (US)
917.13K
3.72%
-10.67K
-1.15%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
872.99K
3.54%
+126.07K
+16.88%
Sep 30, 2025
Schroder Investment Management North America Inc.
796.70K
3.23%
+160.38K
+25.20%
Sep 30, 2025
River Road Asset Management, LLC
651.16K
2.64%
-336.00
-0.05%
Sep 30, 2025
Columbia Threadneedle Investments (US)
763.73K
3.09%
+187.22K
+32.48%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Invesco S&P SmallCap Health Care ETF
1.82%
State Street SPDR S&P Health Care Equipment ETF
1.6%
JPMorgan Active Small Cap Value ETF
0.79%
Invesco S&P SmallCap 600 Pure Growth ETF
0.78%
JPMorgan Fundamental Data Science Small Core ETF
0.68%
Invesco NASDAQ Future Gen 200 ETF
0.51%
iShares S&P Small-Cap 600 Growth ETF
0.47%
State Street SPDR S&P 600 Small Cap Growth ETF
0.41%
OneAscent Enhanced Small and Mid Cap ETF
0.4%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.38%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.82%
State Street SPDR S&P Health Care Equipment ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.6%
JPMorgan Active Small Cap Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.79%
Invesco S&P SmallCap 600 Pure Growth ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.78%
JPMorgan Fundamental Data Science Small Core ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.68%
Invesco NASDAQ Future Gen 200 ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.51%
iShares S&P Small-Cap 600 Growth ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.47%
State Street SPDR S&P 600 Small Cap Growth ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.41%
OneAscent Enhanced Small and Mid Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.4%
Vanguard S&P Small-Cap 600 Growth Index Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.38%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™